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IGM: idiopathic granulomatous mastitisINTRODUCTION
Idiopathic granulomatous mastitis (IGM) is a rare,
chronic inflammatory disease of the breast.1-5 IGM
most commonly affects young, healthy parous
women and usually presents as an ill-defined breast
lump simulating malignancy.1-5 On histopathology,
noncaseating granulomas confined to the breast
lobules are typically seen.1-5 We present a unique
case of IGM that may be of interest to dermatologists
who are not readily familiar with this condition.
CASE REPORT
A 43-year-old previously healthy Hispanic woman
presented to thedermatologyclinic complainingof a 2-
month history of a gradually enlarging, tender left
breast mass. This was accompanied by a 2-week
history of fevers, chills, nonproductive cough, joint
swelling, and pain involving both knees and ankles.
She denied any preceding breast trauma or history of
breast implantation and had no known sick contacts.
Of note, she had previously breastfed all of her
children, having last done so 2 years before the onset
of her symptoms. She had a remote history of Bacillus
Calmette-Guerin vaccination. By the time she pre-
sented to thedermatologydepartment, shehadalready
failed multiple courses of antibiotics for her condition.
A 5-day course of oral corticosteroids prescribed
during one of her emergency room visits resulted in
temporary improvement of all of her symptoms.
On physical examination, the patient was febrile
(38.68C) and inmild respiratory distress with a readily
apparent frequent dry cough. Involving the lateral
and upper quadrants of the left breast, there was an
area of ill-defined,marked induration and tenderness
with no associated nipple discharge or retraction (Fig
1, A). The right breast appeared normal. MultipleHenry Ford Health System, Department of Dermatology.
ources: None.
f interest: None declared.
dence to: Saba Zabetian, MD, 3031 West Grand Blvd,
00, Detroit, MI 48202. E-mail: szabeti2@hfhs.org.
Reports 2016;2:125-7.tender, erythematous nodules were evident on the
arms and legs (Fig 1, B). The remainder of her
physical examination revealed edema and tender-
ness of the bilateral knees and ankles. There was no
appreciable cervical or axillary lymphadenopathy.
A comprehensive laboratory and radiologic
workup was subsequently undertaken. Significant
laboratory findings included a leukocytosis of
16.7 K/L with neutrophilia (80%) and an elevated C-
reactive protein level of 17.2 mg/dL. A chest radio-
graph showed no hilar adenopathy or pulmonary
infiltrates. An ultrasound scan of the left breast mass
revealed mildly dilated inframammary ducts without
any intraductal mass. Three ultrasound-guided core
needle biopsies of the affected area revealed a lobular
proliferation of predominantly histiocytes admixed
with neutrophils. Multinucleate giant cells were also
observed (Fig 2). Special stains including Grocott
methenamine silver and Ziehl-Neelsen were negative
for fungal and mycobacterial organisms.
Given the above findings, a diagnosis of IGM
associated with erythema nodosum, arthritis, and
reactive cough was made. Tuberculosis infection
was ruled out based on a normal chest radiograph
and an absence of caseation and acid-fast staining on
breast biopsy. Sarcoidosis was considered unlikely
given the normal chest radiograph and absence of
the more typical diffuse noncaseating granuloma
pattern on breast biopsy.
The patient was started on prednisone, 80mg daily,
which led toprompt resolutionofher fever, cough, and2352-5126
 2016 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
http://dx.doi.org/10.1016/j.jdcr.2016.01.011
125
Fig 1. A, Markedly firm, indurated, and swollen left breast mass. B, Tender erythematous
nodules on the lower extremities.
Fig 2. Photomicrograph shows a lobular proliferation of
histiocytes along with multinucleate giant cells admixed
with an acute inflammatory infiltrate. (Hematoxylin-eosin
stain.).
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showed significant softening and symptomatic
improvement. After a 3-month course of tapering
prednisone, she was transitioned to azathioprine,
100 mg daily, which she continues to take to maintain
the improvement and control over her disease.DISCUSSION
Kessler andWolloch first described IGM in 1972 as
a rare benign chronic inflammatory disease of the
breast, characterized by presence of noncaseating
granulomas confined to the breast lobules.1-5 The
exact pathogenesis of IGM is unknown, although it is
thought to be immunologically mediated.1-7 IGM
affects young healthy parous women and is often
associated with pregnancy and lactation.1-5 IGM is a
diagnosis of exclusion once infection, malignancy,
foreign body reaction, and other autoimmune
disorders have been ruled out.1-5 Although fever,
chills, and weight loss may be commonly associatedwith IGM, erythema nodosum and arthritis have only
rarely been described.1-5
IGM often has a chronic, relapsing course without
an established standard treatment approach.1-5 The
principle treatment options include surgery, immu-
nosuppressive agents, or a combination of both.2,7-9
Some investigators suggest that systemic corticoste-
roid therapy may be the initial treatment of choice in
IGM, whereas surgical resection should be reserved
for recalcitrant lesions.6,7,10 The thought process
behind this approach is that systemic corticosteroids
usually shrink the breast mass, allowing for a more
conservative surgical resection should the disease
persist.6,8,10 Nonsteroidal immunosuppressive drugs
including azathioprine and methotrexate have been
used successfully in managing IGM.2,5,6,10
Immunosuppressive therapy should be continued
until a complete remission is reached, as recurrence
rates as high as 50% have been reported.9 A recent
prospective cohort study of 49 women with IGM
found that the treatment period required to achieve a
full remission varied from 3 to18 months.7
Alternatively, some investigators propose that IGM
should be treatedwithwide local excision at the onset
of disease, citing a lesser chance of recurrence with
surgical therapy.7,8 However, review of the literature
finds that relapses can still occur despite surgical
resection, and it may require repeated, potentially
deformative surgeries to cure the condition.4,7
Dermatologists should be aware that erythema
nodosum can be one of the presenting signs of
IGM.1-5 Prompt diagnosis and medical treatment of
this rare condition is important, as it may prevent
patients from undergoing potentially disfiguring
surgery. We advocate for an initial trial of
immunosuppressive therapy, as it proved to be
very successful in our patient.
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